MedPath

UNIVERSITY OF PRETORIA

UNIVERSITY OF PRETORIA logo
🇿🇦South Africa
Ownership
Private
Established
1908-01-01
Employees
1K
Market Cap
-
Website
http://www.up.ac.za

Clinical Trials

17

Active:2
Completed:9

Trial Phases

3 Phases

Phase 3:2
Phase 4:3
Not Applicable:9

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Not Applicable
9 (64.3%)
Phase 4
3 (21.4%)
Phase 3
2 (14.3%)

Evaluating the Clinical Effectiveness of a Community-based Hearing Aid Fitting Service Delivery Model Facilitated by Community Healthcare Workers (CHWs) Providing Smartphone-based In-situ and Pre-set Hearing Aid Fittings in Low- and Middle-income Communities (LMICs)

Not Applicable
Active, not recruiting
Conditions
Hearing Loss
First Posted Date
2025-05-21
Last Posted Date
2025-06-24
Lead Sponsor
University of Pretoria
Target Recruit Count
90
Registration Number
NCT06982716
Locations
🇿🇦

Atteridgeville Community, Pretoria, Gauteng, South Africa

🇿🇦

Khayelitsha Community, Cape Town, Western Cape, South Africa

🇿🇦

Paarl Valley, Paarl, Western Cape, South Africa

The Validity of the Use of Imaging in Cervical Cancer Staging

Not yet recruiting
Conditions
Cervical Cancer Stage, Imaging Modalities
First Posted Date
2024-07-05
Last Posted Date
2024-07-05
Lead Sponsor
University of Pretoria
Target Recruit Count
100
Registration Number
NCT06487767
Locations
🇿🇦

Kalafong Provincial Tertiary Hospital, Pretoria, Gauteng Province, South Africa

Efficacy of Using a Closing Pack to Reduce Postpartum Sepsis

Not Applicable
Completed
Conditions
Prevention of Postpartum Sepsis
First Posted Date
2022-11-30
Last Posted Date
2022-11-30
Lead Sponsor
University of Pretoria
Target Recruit Count
1000
Registration Number
NCT05632705
Locations
🇿🇦

Kalafong Provincial Tertiary Hospital, Pretoria, Gauteng Province, South Africa

Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection

Phase 4
Conditions
Prevention of Postpartum Sepsis
Interventions
First Posted Date
2021-03-11
Last Posted Date
2021-03-11
Lead Sponsor
University of Pretoria
Target Recruit Count
1000
Registration Number
NCT04792710
Locations
🇿🇦

Kalafong Provincial Tertiary Hospital, Pretoria, Gauteng Province, South Africa

A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)

Phase 3
Completed
Conditions
Supra-ventricular Tachycardia
Interventions
First Posted Date
2020-05-18
Last Posted Date
2021-06-25
Lead Sponsor
University of Pretoria
Target Recruit Count
30
Registration Number
NCT04392362
Locations
🇿🇦

Steve Biko hospital, Pretoria, Gauteng, South Africa

  • Prev
  • 1
  • 2
  • 3
  • Next

News

Novel Mini-Protein AKY-1189 Shows Promise in Targeted Radiation Delivery for Multiple Cancer Types

AKY-1189, a specially-designed mini-protein, successfully delivers targeted radiation to cancer cells by binding to Nectin-4, a protein expressed in up to 90% of certain cancer types while sparing healthy tissue.

© Copyright 2025. All Rights Reserved by MedPath